MDM2 and cancer: An important p53-controlling molecule often highly expressed in some cancers is MDM2 that inhibits p53 activity by directly binding to it and mediating its ubiquitin-dependent proteolysis, as MDM2 possesses intrinsic E3 ubiquitin ligase activity [11, 12].